ZULIAN, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.830
AS - Asia 3.519
EU - Europa 2.233
AF - Africa 1.096
SA - Sud America 808
OC - Oceania 105
Continente sconosciuto - Info sul continente non disponibili 47
Totale 15.638
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.254
SG - Singapore 1.081
CN - Cina 552
HK - Hong Kong 531
BR - Brasile 470
DE - Germania 276
IT - Italia 245
VN - Vietnam 211
FI - Finlandia 206
PL - Polonia 202
RU - Federazione Russa 126
FR - Francia 82
IN - India 77
SE - Svezia 72
GB - Regno Unito 67
NL - Olanda 67
UA - Ucraina 64
KR - Corea 63
AR - Argentina 60
TR - Turchia 52
MX - Messico 50
AT - Austria 48
CR - Costa Rica 47
IE - Irlanda 45
AE - Emirati Arabi Uniti 44
PA - Panama 42
JO - Giordania 41
ZA - Sudafrica 41
CL - Cile 40
CI - Costa d'Avorio 39
ES - Italia 39
BF - Burkina Faso 38
CZ - Repubblica Ceca 38
ID - Indonesia 38
MG - Madagascar 38
RE - Reunion 38
TH - Thailandia 38
IQ - Iraq 37
SA - Arabia Saudita 37
UG - Uganda 37
AZ - Azerbaigian 36
EC - Ecuador 36
KG - Kirghizistan 36
PE - Perù 36
CO - Colombia 35
CY - Cipro 35
DZ - Algeria 35
KE - Kenya 35
MY - Malesia 35
AM - Armenia 34
HU - Ungheria 34
JP - Giappone 34
JM - Giamaica 33
PH - Filippine 33
YT - Mayotte 33
EG - Egitto 32
GN - Guinea 32
LA - Repubblica Popolare Democratica del Laos 32
PT - Portogallo 32
AL - Albania 31
AO - Angola 31
BB - Barbados 31
BG - Bulgaria 31
GH - Ghana 31
GR - Grecia 31
NE - Niger 31
NI - Nicaragua 31
VE - Venezuela 31
CH - Svizzera 30
HR - Croazia 30
IR - Iran 30
NP - Nepal 30
PK - Pakistan 30
BY - Bielorussia 29
ML - Mali 29
PS - Palestinian Territory 29
RS - Serbia 29
ZM - Zambia 29
CA - Canada 28
CU - Cuba 28
LB - Libano 28
MN - Mongolia 28
SO - Somalia 28
AD - Andorra 27
BE - Belgio 27
CV - Capo Verde 27
DK - Danimarca 27
GA - Gabon 27
IL - Israele 27
LC - Santa Lucia 27
LU - Lussemburgo 27
LY - Libia 27
ME - Montenegro 27
PY - Paraguay 27
SI - Slovenia 27
TJ - Tagikistan 27
UY - Uruguay 27
BA - Bosnia-Erzegovina 26
GT - Guatemala 26
HN - Honduras 26
Totale 14.391
Salva come PNG Salva come JPEG
Città #
Fairfield 1.287
Singapore 711
Ashburn 685
Woodbridge 597
Houston 558
Hong Kong 505
Cambridge 438
Seattle 429
Wilmington 395
Chandler 284
Ann Arbor 282
Santa Clara 192
Beijing 174
Boardman 173
Bytom 169
Jacksonville 162
Princeton 158
Munich 156
San Diego 138
Helsinki 133
Medford 122
Des Moines 89
Los Angeles 68
Dong Ket 66
Ho Chi Minh City 49
Roxbury 49
Chicago 47
Nanjing 46
São Paulo 44
Hefei 43
Panama City 41
Amman 40
Padova 39
San José 37
Abidjan 36
Dublin 36
Hanoi 35
Kampala 35
Vienna 35
Antananarivo 33
Baku 32
Seoul 32
Conakry 31
Managua 31
Ouagadougou 31
Nairobi 30
Bridgetown 29
Lusaka 29
London 28
Ulan Bator 28
Vientiane 28
Accra 27
Bishkek 27
Yerevan 27
Andorra la Vella 26
Bamako 26
Castries 26
Dushanbe 26
Luanda 26
Montevideo 25
Nuremberg 25
Podgorica 25
Dakar 24
Harare 24
Jinan 24
Niamey 24
Nouakchott 24
Salt Lake City 24
Tashkent 24
Turku 24
Mamoudzou 23
New York 23
Phnom Penh 23
Djibouti 22
Havana 22
Praia 22
Pristina 22
Riga 22
Hebei 21
Libreville 21
Noumea 21
Reykjavik 21
Sofia 21
Johannesburg 20
Kingston 20
Nanchang 20
Nassau 20
Willemstad 20
Guayaquil 19
Kigali 19
Kuala Lumpur 19
Tallinn 19
Tirana 19
Zagreb 19
Buffalo 18
Dar es Salaam 18
Dubai 18
Gaborone 18
Nicosia 18
Budapest 17
Totale 10.028
Salva come PNG Salva come JPEG
Nome #
Case report: Exploring under the tip of the iceberg: A case series of "self-limiting" multisystem inflammatory syndrome in children 258
A new computerized method for the assessment of skin lesions in Localized Scleroderma 200
2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Juvenile Dermatomyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative 192
Consensus-based recommendations for the management of juvenile localised scleroderma 180
Synovial hemangioma of infrapatellar (Hoffa) fat pad: Magnetic resonance imaging and ultrasound features 175
Anti-DFS70 antibodies in healthy schoolchildren: A follow-up analysis 169
CXCR3/CXCL10 expression in the synovium of children with juvenile idiopathic arthritis 166
Reduced levels of circulating progenitor cells in juvenile idiopathic arthritis are counteracted by anti TNF-α therapy. 163
Musculoskeletal pain in schoolchildren across puberty: A 3-year follow-up study 154
Life-threatening systemic capillary leak syndrome in juvenile dermatomyositis 151
A long-term follow-up study of methotrexate in juvenile localized scleroderma (morphea) 145
Abatacept for severe anti-tumor necrosis factor α refractory juvenile idiopathic arthritis-related uveitis 143
Longterm safety and efficacy of adalimumab and infliximab for uveitis associated with juvenile idiopathic arthritis 141
THU0532 RITUXIMAB FOR RAPIDLY PROGRESSIVE JUVENILE SYSTEMIC SCLEROSIS 141
Severe clinical course of systemic lupus erythematosus in the first year of life 140
Congenital localized scleroderma 140
Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: Results from a phase 3, randomised, double-blind withdrawal trial 136
Long-term outcome and prognostic factors of juvenile dermatomyositis: A multinational, multicenter study of 490 patients 135
Disease course and long-term outcome of juvenile localized scleroderma: Experience from a single pediatric rheumatology Centre and literature review 133
Monoarticular juvenile chronic arthritis of the shoulder: Report of a case and review of the literature 133
Update of EULAR recommendations for the treatment of systemic sclerosis 132
CXCR6-CXCL16 interaction in the pathogenesis of Juvenile Idiopathic Arthritis. 131
Methotrexate treatment in juvenile localized scleroderma: a randomized, double-blind, placebo-controlled trial. 131
Sarcopenia in juvenile localized scleroderma: new insights on deep involvement 130
Prednisone versus prednisone plus ciclosporin versus prednisone plus methotrexate in new-onset juvenile dermatomyositis: A randomised trial 129
Localized scleroderma of the face 129
Prevalence of antinuclear antibodies in schoolchildren during puberty and possible relationship with musculoskeletal pain: A longitudinal study 128
Consensus-based recommendations for the management of juvenile systemic sclerosis 128
Loss of efficacy during long-term infliximab therapy for sight-threatening childhood uveitis 127
Juvenile localized scleroderma: clinical and epidemiological features in 750 children. An international study 125
Reliability of LoSCAT score for activity and tissue damage assessment in a large cohort of patients with Juvenile Localized Scleroderma 125
A computerized method to assess the skin involvement in localized scleroderma. 124
A diagnostic score for molecular analysis of hereditary autoinflammatory syndromes with periodic fever in children 124
A preliminary disease severity score for juvenile systemic sclerosis 124
Clinical features and outcome of cogan syndrome 123
Electrocardiographic abnormalities in infants born from mothers with autoimmune diseases - a multicentre prospective study 120
Comparison of intra-articular triamcinolone hexacetonide and triamcinolone acetonide in oligoarticular juvenile idiopathic arthritis 120
Comparable efficacy of abatacept used as first-line or second-line biological agent for severe juvenile idiopathic arthritis-related uveitis 120
Recent advances in the management of juvenile systemic sclerosis 119
Triamcinolone acetonide and hexacetonide intra-articular treatment of symmetrical joints in juvenile idiopathic arthritis: a double-blind trial 118
Case Report: Life-Threatening Macrophage Activation Syndrome With Fulminant Myocarditis Successfully Rescued by High Dose Intravenous Anakinra 118
The PRINTO evidence-based proposal for glucocorticoids tapering/discontinuation in new onset juvenile dermatomyositis patients 115
Bone involvement as presenting sign of pediatric-onset Gaucher disease 115
Photopheresis in paediatric patients with drug-resistant chronic graft-versus-host disease. 113
Safety and efficacy of infliximab and adalimumab for refractory uveitis in juvenile idiopathic arthritis: 1-year followup data from the Italian Registry 111
Distinctive clinical features of pediatric systemic lupus erythematosus in three different age classes 110
Early predictors at severe course of uveitis in oligoarticular Juvenile idiopathic arthritis 110
CXCL10/CXCR3 interaction mediate chemotaxis of T cell into the synovium of children with oligoarticular juvenile idiopathic arthritis. 110
The European network for care of children with paediatric rheumatic diseases: care across borders 110
Bone marrow edema in children: chronic nonbacterial osteomyelitis and its mimickers 107
Subset-specific effects of sex hormones and pituitary gonadotropins on human lymphocyte proliferation in vitro 107
The pediatric rheumatology European Society American College of Rheumatology European league against rheumatism provisional classification criteria for juvenile systemic sclerosis 106
Follow-up and quality of life of patients with cryopyrin-associated periodic syndromes treated with Anakinra 106
Joint hypermobility and oligoarticular juvenile idiopathic arthritis: What relationship? 105
Immunopathogenesis of pediatric localized scleroderma 105
Osteoperiostitis in children: proposal for a diagnostic algorithm 105
Relapses of juvenile idiopathic arthritis in adulthood: A monocentric experience 104
Successful treatment of gangrene in systemic necrotizing vasculitis with iloprost 104
Case of the month: A five-year-old girl with intractable arthralgias 104
CXCL10/CXCR3 interaction mediate chemotaxis of T cell into the synovium of children with oligoarticular juvenile idiopathic arthritis. 104
Otolaryngological manifestations of rheumatic diseases in children. 103
Juvenile idiopathic arthritis: Current and future treatment options 103
Growth during tocilizumab therapy for polyarticular-course juvenile idiopathic arthritis: 2-year data from a phase III clinical trial 102
Infrared thermography in children: A reliable tool for differential diagnosis of peripheral microvascular dysfunction and Raynaud's phenomenon? 102
Acquired strabismus in linear scleroderma of the face 101
Treatment in Juvenile Scleroderma 101
Performance of the preliminary definition of improvement in juvenile chronic arthritis patients treated with methotrexate 100
Cone beam computed tomography for the assessment of linear scleroderma of the face 100
Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis 99
Systemic sclerosis in childhood: Clinical and immunologic features of 153 patients in an international database 99
A child with dermatomyositis and a suspicious lymphadenopathy. 98
Juvenile and young adult-onset systemic sclerosis share the same organ involvement in adulthood: Data from the Eustar database 98
Psychological profile in children and adolescents with severe course Juvenile idiopathic arthritis 98
Clinical impact of MEFV mutations in children with periodic fever in a prevalent western European Caucasian population 97
Joint hypermobility, growing pain and obesity are mutually exclusive as causes of musculoskeletal pain in schoolchildren 96
Methotrexate: New uses for an old drug 96
Immunopathogenesis of juvenile systemic sclerosis 96
Systemic Sclerosis and Localized Scleroderma in Childhood 96
New Insights on Juvenile Psoriatic Arthritis 95
Scleroderma in children: An update 95
Prolactin receptor levels on lymphocytes vary with menstrual cycle in women 95
New developments in localized scleroderma 95
Natural history and extracutaneous involvement of congenital morphea: Multicenter retrospective cohort study and literature review 95
Scleroderma in children 95
Temporomandibular Joint Involvement in Association With Quality of Life, Disability, and High Disease Activity in Juvenile Idiopathic Arthritis 95
The 1982 ARA/ACR criteria for theclassification of systemic lupus erythematosus in pediatric and adult patients 94
Methotrexate in Linear Scleroderma: long-term efficacy in 50 children from a single Pediatric Rheumatology Centre 94
Juvenile diabetes and systemic sclerosis: just a coincidence? 93
Reflex sympathetic dystrophy in children 93
Health related quality of life measure in systemic pediatric rheumatic diseases and its translation to different languages: An international collaboration 93
Mycophenolate mofetil for methotrexate-resistant juvenile localized scleroderma 93
Evolution of echocardiographic and cardiac magnetic resonance imaging abnormalities during follow-up in patients with multisystem inflammatory syndrome in children 91
Early echocardiographic and cardiac mri findings in multisystem inflammatory syndrome in children 91
Outcome measures and medical progress: why outcome measures are needed in childhood arthritis 90
Localized scleroderma 90
Periodic fevers with aphthous stomatitis, pharyngitis, and adenitis (PFAPA) 90
Is there a role for arthroscopic synovectomy in oligoarticular juvenile idiopathic arthritis? 89
The schedule of administration of canakinumab in cryopyrin associated periodic syndrome is driven by the phenotype severity rather than the age 89
Is Intraarticular Corticosteroid Injection (IAC) an effective therapy for Temporomandibular Joint (TMJ) Involvement in JIA? 88
The interferon-gamma pathway is selectively up-regulated in the liver of patients with secondary hemophagocytic lymphohistiocytosis 88
Totale 11.687
Salva come PNG Salva come JPEG
Categoria #
all - tutte 51.622
article - articoli 48.739
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 346
Totale 100.707
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.277 0 0 0 137 157 51 29 183 252 130 225 113
2021/20221.638 56 192 176 129 90 60 83 166 191 36 122 337
2022/2023800 231 44 22 50 122 110 9 52 96 14 41 9
2023/2024567 21 75 69 36 57 33 52 24 27 9 76 88
2024/20253.149 25 189 82 90 435 129 180 240 308 113 575 783
2025/20265.470 499 1.152 1.947 1.872 0 0 0 0 0 0 0 0
Totale 15.851